Personalized peptide vaccines and their relation to other therapies in urological cancer
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Urology"
DOI: 10.1038/nrurol.2017.77
Abstract: Immunotherapy is an important therapeutic modality for urological cancers and several immunological agents for their treatment, such as sipuleucel-T and immune checkpoint inhibitors, have been approved by the FDA. Personalized peptide vaccines (PPVs) are an… read more here.
Keywords: personalized peptide; peptide vaccines; vaccines relation; urological cancers ... See more keywords